Search

Your search keyword '"Heneka, Michael T."' showing total 186 results

Search Constraints

Start Over You searched for: Author "Heneka, Michael T." Remove constraint Author: "Heneka, Michael T." Topic alzheimer's disease Remove constraint Topic: alzheimer's disease
186 results on '"Heneka, Michael T."'

Search Results

1. Identification of isoAsp7-Aβ as a major Aβ variant in Alzheimer’s disease, dementia with Lewy bodies and vascular dementia

2. Perivascular space enlargement accelerates in ageing and Alzheimer’s disease pathology: evidence from a three-year longitudinal multicentre study

6. Impact of COVID‐19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research

7. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer’s disease: results from the DELCODE study

8. Exploring the ATN classification system using brain morphology

9. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers

10. Passive anti-amyloid β immunotherapy in Alzheimer's disease—opportunities and challenges.

11. Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum.

13. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease

15. The putative contribution of cellular senescence to driving tauopathies.

16. NLRP3‐directed antisense oligonucleotides reduce microglial immunoactivities in vitro.

17. Neuroinflammation in Alzheimer's disease

18. Improving 3D convolutional neural network comprehensibility via interactive visualization of relevance maps: evaluation in Alzheimer’s disease

20. Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.

21. Inferior Frontal Sulcal Hyperintensities on Brain MRI Are Associated with Amyloid Positivity beyond Age—Results from the Multicentre Observational DELCODE Study.

24. Innate immune activation in neurodegenerative diseases.

25. Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.

26. Inflammasomes in neurological disorders — mechanisms and therapeutic potential.

27. Non-target LC-HRMS to Study the Exposome of Mild Cognitive Impairment and Alzheimer's Disease on Cerebrospinal Fluid

28. Phosphorylation-state dependent intraneuronal sorting of Aβ differentially impairs autophagy and the endo-lysosomal system.

29. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

31. A Residual Marker of Cognitive Reserve Is Associated with Resting-State Intrinsic Functional Connectivity Along the Alzheimer's Disease Continuum

36. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

37. Sporadic Use of Antibiotics in Older Adults and the Risk of Dementia: A Nested Case–Control Study Based on German Health Claims Data.

38. APOE and immunity: Research highlights.

39. The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap.

40. Cholinergic white matter pathways along the Alzheimer's disease continuum.

41. Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease

47. Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction.

48. Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study

49. ApoE4 makes microglia trem2bling.

50. Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer's disease pathology.

Catalog

Books, media, physical & digital resources